ASX - By Stock
|
GSR |
Re:
Ann: Receipt of Shareholder Voting Intention Statements
|
|
Micko22
|
16 |
3.4K |
6 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
16
|
3.4K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
66 |
14K |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
66
|
14K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
66 |
14K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
66
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
66 |
14K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
66
|
14K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
66 |
14K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
66
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
Micko22
|
66 |
14K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
66
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First patient treated with OncoSil device in Turkiye
|
|
Micko22
|
8 |
2.2K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
8
|
2.2K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
Micko22
|
26 |
5.9K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
26
|
5.9K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
Micko22
|
26 |
5.9K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
26
|
5.9K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
Micko22
|
26 |
5.9K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
26
|
5.9K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Micko22
|
40 |
9.7K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
40
|
9.7K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Micko22
|
40 |
9.7K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
40
|
9.7K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Micko22
|
40 |
9.7K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
9.7K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Micko22
|
40 |
9.7K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
9.7K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
Micko22
|
118 |
30K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
118
|
30K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
Micko22
|
118 |
30K |
0 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
118
|
30K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
Micko22
|
118 |
30K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
118
|
30K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
SOFDRA market size
|
|
Micko22
|
57 |
21K |
11 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
57
|
21K
|
11
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
13K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
13K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
13K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
13K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
13K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
13K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
13K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
13K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
13K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
13K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
13K |
2 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
13K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Micko22
|
58 |
13K |
0 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
58
|
13K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.0K |
2.9M |
5 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
12K |
4.2M |
3 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
12K
|
4.2M
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Why OSL is a Multi-Bagger
|
|
Micko22
|
55 |
21K |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
55
|
21K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.0K |
2.9M |
19 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
19
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
Micko22
|
39 |
10K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
39
|
10K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
Micko22
|
39 |
10K |
1 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
39
|
10K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
Micko22
|
39 |
10K |
7 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
10K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Micko22
|
14 |
3.4K |
11 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
14
|
3.4K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Application for quotation of securities - BOT
|
|
Micko22
|
11 |
3.7K |
3 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
11
|
3.7K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Successful Completion of Human Factors Study
|
|
Micko22
|
52 |
14K |
14 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
52
|
14K
|
14
|
|
ASX - By Stock
|
OSL |
Re:
AGM 2023 & Resolutions
|
|
Micko22
|
17 |
7.0K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
17
|
7.0K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
12K |
4.2M |
9 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
12K
|
4.2M
|
9
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
Micko22
|
67 |
23K |
0 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
67
|
23K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
Micko22
|
67 |
23K |
1 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
67
|
23K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
Micko22
|
67 |
23K |
1 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
67
|
23K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
Micko22
|
13 |
2.8K |
0 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
13
|
2.8K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
Micko22
|
13 |
2.8K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
13
|
2.8K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
Micko22
|
13 |
2.8K |
0 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
13
|
2.8K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Micko22
|
12K |
4.2M |
4 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
12K
|
4.2M
|
4
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Medical AGM on 29th of November 2023
|
|
Micko22
|
3 |
1.1K |
1 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
3
|
1.1K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil gaining traction in the Israeli healthcare market
|
|
Micko22
|
6 |
2.4K |
2 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
6
|
2.4K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil gaining traction in the Israeli healthcare market
|
|
Micko22
|
6 |
2.4K |
2 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
6
|
2.4K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil gaining traction in the Israeli healthcare market
|
|
Micko22
|
6 |
2.4K |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
6
|
2.4K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.0K |
2.9M |
0 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Micko22
|
8.0K |
2.9M |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
8.0K
|
2.9M
|
3
|
|